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Abstract: The bioactivity of a series of fluoride-containing sodium-free calcium and 
strontium phosphosilicate glasses has been tested in vitro. Glasses with high fluoride 
content were partially crystallised to apatite and other fluoride-containing phases.  
The bioactivity study was carried out in Tris and SBF buffers, and apatite formation was 
monitored by XRD, FTIR and solid state NMR. Ion release in solutions has been measured 
using ICP-OES and fluoride-ion selective electrode. The results show that glasses with low 
amounts of fluoride that were initially amorphous degraded rapidly in Tris buffer and 
formed apatite as early as 3 h after immersion. The apatite was identified as fluorapatite by 
19
F MAS-NMR after 6 h of immersion. Glass degradation and apatite formation was 
significantly slower in SBF solution compared to Tris. On immersion of the partially 
crystallised glasses, the fraction of apatite increased at 3 h compared to the amount of 
apatite prior to the treatment. Thus, partial crystallisation of the glasses has not affected 
bioactivity significantly. Fast dissolution of the amorphous phase was also indicated. There 
was no difference in kinetics between Tris and SBF studies when the glass was partially 
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crystallised to apatite before immersion. Two different mechanisms of apatite formation for 
amorphous or partially crystallised glasses are discussed. 
Keywords: sodium-/alkali-free bioactive glass; bioactive glass-ceramics; fluorapatite; fluoride 
 
1. Introduction 
The bioactivity of glasses and ceramics is often investigated on immersion of the solid in a buffer 
solution simulating physiological fluids. Formation of an apatite-like layer on the surface of the solid 
as a result of the reaction with fluid is then evaluated. This laboratory procedure has a number of 
drawbacks and cannot be used directly for predicting the bioactivity of the same solid in vivo [1,2]. 
However, testing apatite formation in buffer solution is a useful inexpensive model for comparative 
evaluation of the bioactive glasses and bioceramics of different formulations in order to preselect 
compositions with potentially the most promising biological activity.  
The earliest immersion time when apatite can be identified is typically used as a measure of 
bioactivity. However, the rate and ability of bioceramics to form apatite is dependent on the type of 
physiological buffer used even when the same formulation of bioceramics or glass is tested. In 
particular, concentrations of calcium and phosphate available in solution as well as the presence of 
other species affect the rate of apatite formation. The composition of the simulated body fluid (SBF) 
solution is close to the saturation level of apatite [2]. Therefore, potentially any surface exposed to 
SBF can aid precipitation of apatite irrespective of whether it is bioactive or not. On the other hand, 
only calcium- and phosphate-rich bioceramics and glasses can be tested for bioactivity in Tris buffer 
solution, owing to apatite precipitation following the initial release of these components from the solid 
into solution.  
Alkali- or specifically sodium-containing bioactive glasses generate a high alkaline pH that can 
cause a cytotoxic cells response [3]. Although plenty of alkali-free bioceramics [4,5] based on  
calcium-rich crystalline phases have been studied including phosphates [6], carbonates [7] and  
silicates [8,9], there are only few reports on alkali-free bioactive glasses [10–16]. The majority of the 
available sodium-free bioactive glasses are of sol-gel origin [17–22], and the nominal composition of 
these glasses cannot be directly compared with melt-derived glasses owing to the presence of 
substantial amounts of, if not water, then hydroxyl groups in the glass. In a report where exclusively 
sodium-free melt-derived glasses were studied, the bioactivity of the glasses was clearly inhibited 
owing to the presence of significant amounts of MgO in the composition [12]. 
Typically, the rate of apatite formation is lower for ceramics than for amorphous glasses, as a 
crystalline solid has a lower dissolution rate and thus would be expected to exhibit lower bioactivity 
than an amorphous glass of a bioactive-type composition. For instance, sintered apatite bioceramics 
dissolves slower than apatite resulting from the degradation of bioactive glass [23]. Sintered glass 
exhibits a bioactivity lower than the one before sintering [24]. Moreover, partial crystallisation  
often occurs during sintering, for instance with 45S5, which will further decrease the reactivity of  
the glass [25–27]. 
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Recent success in fluoride-containing bioactive glasses showed that there is a concentration limit 
for fluoride to be added to the glass before spontaneous crystallisation occurs [10,11,28–30]. This is 
owing to the known effect of fluoride destabilising glass against crystallisation [31]. It is also known 
that the type of the fluoride-containing crystalline phase is dependent on the composition of the glass. 
For example, in low phosphate content bioactive glasses, calcium fluoride crystallises out [32].  
An increase in phosphate content caused formation of apatite in the glasses [33].  
In the present study, the design of glasses is typical for bioactive compositions [34,35] and it is such 
that the silicate component is present mostly as chains [32,36,37], while fluoride is coordinated by  
calcium [38] and phosphate is present as orthophosphate [32,36]. Partial crystallisation of an apatite 
phase should not involve the silicate chain domains [32,33,38,39], and these will still remain 
amorphous, which means the silicate phase would still continue to dissolve rapidly. In addition, apatite 
crystals pre-formed in the system can minimise the nucleation energy via providing their surface for 
further precipitation and growth of the apatite crystals. Although apatite-containing systems have been 
known before, none of the bioactivity studies considered this in combination with a reactive glass 
phase. We propose that the bioactivity of these glasses will not be significantly affected by partial 
crystallisation of the glasses. 
Thus, the aim of this paper is to investigate the bioactivity of sodium-free amorphous or partially 
crystallised glasses and compare the bioactivity of the two. 
2. Results and Discussion 
2.1. Apatite Formation  
2.1.1. X-ray Diffraction (XRD) Results 
XRD results of four compositions after immersion in Tris and SBF solutions are presented in  
Figure 1a–h. The compositions with 3 mol% CaF2 and SrF2 were amorphous as quenched, whereas 
compositions with 9.3 mol% CaF2 and SrF2 were partially crystallised upon quenching. 
In Figure 1a,b, clear characteristic apatite peaks developed at 25.9° and 31.8° 2 after short 
immersion times. The intensities of these diffraction lines increased with immersion time. However, it 
is seen that the intensities grew more rapidly in Tris buffer compared to SBF. The presence of 
significant amounts of apatite is revealed in the XRD patterns after immersion in Tris between 3 and 9 h, 
whereas a similar intensity of the apatite diffraction lines is seen after immersion in SBF for 3 days 
only. Immersions for durations longer than 9 h in Tris and 3 days in SBF did not reflect significant 
changes on the XRD patterns. Similar results were obtained for compositions with 0, 4.5, and 6 mol% 
CaF2 (not shown). 
Glasses with higher CaF2 content that had partially crystallised to mainly fluorapatite (FAP) also 
exhibited bioactivity. As seen from Figure 1c,d, the intensity of apatite peaks increased after 
immersion compared to the non-immersed glass. However, there was no significant difference in the 
intensity of the apatite diffraction lines obtained after immersion in Tris and SBF for the same time 
period. It is clearly seen that the apatite diffraction lines are significantly broader for the compositions 
with low CaF2 content (Figure 1a,b) than for the compositions with high CaF2 content (Figure 1c,d) 
owing to the presence of crystalline FAP in the untreated glasses with high CaF2 content. 
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Figure 1. XRD patterns of glasses after immersion in buffer solutions: (a) GF 3.0 in Tris; 
(b) GF 3.0 in SBF; (c) GF 9.3 in Tris; (d) GF 9.3 in SBF; (e) SF 3.0 in Tris; (f) SF 3.0  
in SBF; (g) SF 9.3 in Tris; (h) SF 9.3 in SBF. Label Ap in CaF2 series is fluorapatite 
Ca5(PO4)3F (00-034-0011), and strontium fluorapatite Sr5(PO4)3F in SrF2 series  
(00-050-1744). 
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Figure 1. Cont. 
  
(g) (h) 
Figure 1e,h show the XRD patterns of SrF2-containing glasses after immersion, and the results are 
similar to those seen in the CaF2 series. The diffraction peaks at 30.5° and 31.7° 2, which correspond 
to strontium phosphate fluoride (Sr10(PO4)6F2), developed after immersion of the composition with  
3 mol% SrF2 in Tris and SBF (Figure 1e,f). The intensity of the apatite diffraction lines after 
immersion in Tris is much stronger than after immersion in SBF. However, the difference in intensity 
after immersion in Tris or SBF is not significant when the SrF2-containing glass contains crystalline 
fractions of apatite as observed for the composition with 9.3 mol% SrF2 (Figure 1g,h). 
Thus, for both the CaF2 and SrF2 series, the fraction of apatite detected from the XRD patterns grew 
faster during immersion in Tris than in SBF solution when the immersed glass powders were XRD 
amorphous before immersion. The higher initial intensity of the apatite lines for the partially 
crystallised glasses indicates that the apatite crystals present in the untreated glass served as nuclei for 
the apatite phase formed during immersion in buffer solution, and newly formed apatite crystals 
precipitated on the surface of the pre-existing crystalline phase. 
2.1.2. Fourier Transform Infrared (FTIR) Spectroscopy Results 
FTIR spectroscopy was used to monitor glass degradation and apatite formation upon immersion of 
glasses in buffer solution, and Figure 2a–h presents the FTIR results for the same four compositions 
shown in Figure 1. Each bottom spectrum in Figure 2 corresponds to the non-immersed glass powder 
mainly showing three strongly overlapped bands at about 1000, 920 and 870 cm
−1
, which are known 
for bioactive type silicate glass and are assigned to the Si-O vibration modes, i.e., Si-O-Si stretch,  
non-bridging oxygen Si-O
−
 stretch and bend, respectively [10]. This assignment is consistent with the 
IR spectra computed by using accurate DFT calculations recently reported for phosphosilicate 
bioactive glasses [40,41]. The spectra of the samples collected after immersion reveal clear changes 
compared to the non-immersed glasses. 
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Figure 2. FTIR spectra of glasses after immersion in buffer solutions: (a) GF 3.0 in Tris; 
(b) GF 3.0 in SBF; (c) GF 9.3 in Tris; (d) GF 9.3 in SBF; (e) SF 3.0 in Tris; (f) SF 3.0 in SBF; 
(g) SF 9.3 in Tris; (h) SF 9.3 in SBF. 
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Figure 2. Cont. 
  
(g) (h) 
The non-bridging oxygen Si-O
−
 band at 920 cm
−1
 decreased in intensity immediately upon 
immersion and disappeared at longer immersion times. All the spectra clearly show sharpening of the 
band at about 1035 cm
−1
 which is associated with both Si-O-Si and crystalline orthophosphate. The 
latter additionally accounts for the shoulder appearing at about 1100 cm
−1
 [10,11]. However, it is seen 
that the sharpening occurs more rapidly during immersion in Tris rather than SBF. Very clear changes 
can be seen in the region 500–600 cm−1. The typical crystalline orthophosphate or apatite split bands at 
560 cm
−1
 and 613 cm
−1
 are present for GF 3.0 glass at 3 h immersion in Tris (Figure 2a) and can be 
distinguished at 9 h of immersion in SBF (Figure 2b). The spectra indicating the presence of crystalline 
apatite have another band at about 960 cm
−1
 corresponding to the P-O stretch in the orthophosphate 
tetrahedron. The spectra for the samples collected after immersion contain bands at 1450, 1420 and 
870 cm
−1
, which are associated with the presence of carbonate substitution in the apatite. The band at 
790 cm
−1
 appearing in the spectra after immersion is assigned to Si-O-Si between the two adjacent 
silicate tetrahedra [11,42]. This forms as a result of condensation reactions on glass degradation and 
essentially presents a silica-gel. Figure 2a shows that starting from 6 h of immersion the spectra  
are very similar to each other. No changes can be seen in the spectra at 24 h of immersion in SBF 
(Figure 2b). 
The evolution of bands in the FTIR spectra for the GF 9.3 composition after immersion in Tris and 
SBF (Figure 2c,d) is similar to the one observed for glass GF 3.0. The spectrum of the original glass 
reveals signs of the presence of crystalline FAP in addition to the typical bands of Si-O vibration. On 
immersion, the spectra clearly reveal changes owing to glass dissolution. In addition, it is seen that the 
sharpening of the bands occurs at earlier time points after immersion in Tris than in SBF. Similar 
results were obtained for other compositions with CaF2 contents higher than 9.3 mol% (not shown). 
The FTIR spectra of SF 3.0 and SF 9.3 (Figure 2e–h) reveal similar results for the SrF2-containing 
series. Upon immersion, non-bridging oxygen band disappeared, and a crystalline orthophosphate band 
develops. The position of the split bands characteristic for crystalline orthophosphate is slightly 
different from the CaF2 series. These developed at 590 and 555 cm
−1
 which may be explained by  
the presence of strontium cations [39]. The FTIR spectra of SF 9.3 are similar to those of other 
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compositions with SrF2 contents higher than 3.0 mol%. The differences in the rate of sharpening of the 
FTIR bands in Tris compared to SBF immersion is clearly seen in this series, too. 
On comparison with the calcium series, it is seen that the spectrum of SF 3.0 immersed in Tris for  
1 day (Figure 2e) displays sharper features than the spectrum of GF 3.0 at the same immersion time 
(Figure 2a), which indicates that the strontium-containing glass may dissolve and form apatite slightly 
faster than the calcium-containing one. FTIR spectroscopy characterises both amorphous and 
crystalline species present in solids unlike XRD, which reveals changes in the crystalline domains of a 
solid only. The presented FTIR results indicate that glass dissolution may occur faster in Tris buffer 
solution than in SBF for amorphous or partially crystallised bioactive silicate glasses. 
2.1.3. Magic Angle Spinning-Nuclear Magnetic Resonance (MAS-NMR) Spectroscopy Results 
Figure 3 displays the 
31
P and 
19
F MAS-NMR spectra of the calcium fluoride-containing series 
immersed for 6 h in Tris buffer; the spectra are plotted for increasing fluoride content from bottom to 
top. The 
31
P MAS-NMR spectra in Figure 3a are very similar for the entire series and reveal a 
relatively sharp peak with the centre between 2.8 and 3.0 ppm, assigned to crystalline apatite [43]. 
Some of the spectra show an asymmetry of the signal indicating presence of multiple phosphorus 
species that can include the residual glass signal as well. The latter is expected to be around 3 ppm, 
though is broader than the signal assigned to apatite. 
Figure 3. 
31
P (a) and 
19
F (b) MAS-NMR spectra of the samples collected after immersion 
in Tris buffer solution for 6 h. 
  
(a) (b) 
The 
19
F MAS-NMR spectra shown in Figure 3b revealed multiple overlapping signals including the 
crystalline species of a fluoride-substituted apatite with a signal at about −103 ppm and calcium 
fluoride at about −108 ppm characterised by a sharp peak [11]. No crystalline calcium fluoride appears 
to be presence in the spectra of the compositions with low fluoride content (GF 3.0, GF 4.5 and GF 6.0); 
these glass compositions showed only formation of fluorapatite during immersion. The asymmetry of 
the signal is explained by the presence of fluoride species in the residual glass; the spectra of the initial 
glasses are characterised by a broad signal at about −95 ppm [39]. Starting from composition GF 9.3 
the sharp feature at about −108 ppm corresponding to CaF2 can be distinguished in the spectra  
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(Figure 3b), increasing in intensity at higher fluoride contents in the glass. Finally, in composition GF 
25.5, most of the fluoride is present as crystalline calcium fluoride at 6 h immersion in Tris, although a 
crystalline fluorapatite in addition to calcium fluoride and fluorine in the glass phase was detected in 
the original glass before immersion. 
The MAS-NMR results in Figure 3 indicate that 6 h immersion of the glass powders in Tris buffer 
produced a fluoride-substituted apatite as the major solid phase in most of the compositions. Although 
this result is consistent with those obtained from XRD and FTIR, the results from 
19
F NMR in  
Figure 3b provide evidence that the apatite formed is fluoride-substituted. The 
31
P MAS-NMR spectra 
of this glass series at 9 h of immersion were similar to the spectra in Figure 3a (6 h), although the line 
width decreased slightly at 9 h of immersion compared to 6 h. However, in the glass with the highest 
fluoride content most of the fluoride was detected as crystalline CaF2 with only a small fraction of 
fluorapatite present. In addition, for the composition GF 25.5, the spectra of 6 and 9 h of immersion 
are practically identical. The latter is consistent with the XRD results, where the patterns were 
practically identical. 
The 
31
P NMR spectra of the partially crystallised glasses that contained an apatite phase before 
immersions (GF 9.3, GF 13.6, GF 17.8) were deconvolved [44], and the results show an increase in the 
apatite fraction at 9 h of immersion compared to the immersion for 6 h and the fraction of apatite in the 
untreated glass. A fraction of 20%–30% of the original phosphorus in GF 9.3, GF 13.6, GF 17.8 
glasses was crystallised to an apatite; this increased up to 30%–40% at 6 h of immersion, which further 
increased to 40%–50% at 9 h of immersion in Tris. This indicates that the crystalline apatite formed in 
the glass spontaneously during quenching can serve as a seeding phase for the apatite precipitating 
during immersion in physiological solutions. This may also affect the morphology of the apatite formed 
on precipitation; the bigger apatite crystals of a more regular shape that formed spontaneously during 
glass quenching can further grow during immersion in buffer solution, whereas small nanometre-sized 
apatite crystals were formed when an amorphous bioactive glass powder was immersed in buffer  
solution [45].  
2.2. Dissolution Study 
2.2.1. pH Measurements Results 
Figure 4 shows pH changes in Tris buffer solution during immersion of glass powders measured  
at the end of the immersion time. The general trend is similar for all compositions: pH increased on 
initial immersion, which is explained by substitution of protons from the solution for the cationic 
components of the glass, which increases the alkalinity of the solution. However, as the apatite phase 
starts precipitating, pH does not increase any longer and may even slightly decrease. It is seen that the 
highest increase in pH at the initial stage was observed for the fluoride-free glass GF 0.0. This is 
consistent with the effect of fluoride incorporated into a bioactive glass to reduce an increase in pH on 
initial dissolution which was previously seen and discussed [11,46]. However, overall, it is seen that 
the strontium-containing glasses gave a slightly lower pH during dissolution (mostly between 7.5 and 7.6) 
than the calcium-containing ones (mostly between 7.6 and 7.7). 
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Figure 4. pH measured at the end of the immersion time in Tris buffer. Open symbols are 
for the CaF2 series (GF) and closed symbols are for the SrF2 series (SF) with the same 
nominal fluoride content. 
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2.2.2. Ion Release Results 
Figure 5a presents the relative phosphate concentration in Tris solution at 9 hours’ immersion of 
glass powders of the calcium fluoride series, presented as a percentage of the phosphate in the nominal 
glass composition. It is seen that two different trends are observed depending on whether the original 
glass was amorphous or contained a crystalline phase. Amorphous glasses with low fluoride content 
show only presence of very small percentages (less than 2%) of phosphate in solution. By contrast, the 
partially crystallised glasses containing high amounts of fluoride show higher concentrations (up to 
11% of phosphate) at early time points (1 h), followed by a decrease in phosphate concentration, which 
is consistent with the precipitation of an apatite phase during which phosphate is consumed. The 
higher the fluoride content in the glass, the higher the phosphate concentration at 1 h. However, the 
subsequent drop in the release was most pronounced for the GF 25.5 glass composition. 
The concentrations of calcium and strontium from the glass powders upon immersion up to 1 week 
are presented in Figure 5b. It is seen that at 24 h of immersion 40%–50% of calcium and strontium are 
present in solution, and this concentration does not change significantly at the later time points. There 
seems to be no trend with fluoride content. 
The percentage of fluoride present in Tris buffer is shown in Figure 5c for 3 and 6 h of immersion. 
It is seen that the highest concentration (over 35% of the nominal fluoride content in the glass) was 
observed for composition GF 9.3. However, the lowest concentration of fluoride (about 10%) is seen 
for the glass with the highest fluoride content, GF 25.5, although most of the fluoride in the original 
composition was in the crystalline phase as seen from its 
19
F MAS-NMR spectrum. There was only  
a small difference between fluoride concentrations at 3 and 6 h of immersion, which is at the level of 
accuracy of the measurements. Thus, it is seen that fluoride concentrations increase with increase in 
fluoride content in the glass as long as fluoride remains in the amorphous glass. Once a fluoride-containing 
phase starts crystallising from the glass the fluoride concentrations decrease. This suggests that  
the amorphous fluoride-containing glass phase is the source of the fluoride release rather than the 
crystalline phase. 
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Figure 5. (a) The percentage of phosphate presented as concentration of elemental 
phosphorus in Tris for CaF2-containing glasses; (b) The percentage of cations (Sr
2+
 or Ca
2+
) 
concentration in Tris; (c) The percentage of fluoride concentration measured at 3 and 6 h in 
Tris for CaF2-containing glasses. 
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2.3. Final Discussion 
This study presents bioactivity data for two fluoride-containing series of glasses that were either 
amorphous or partially crystallised. Those glasses which had partially crystallised can be considered as 
fluoride-containing glass-ceramics. All the glasses and glass-ceramics showed fast glass degradation 
and apatite formation upon immersion in buffer solutions. However, the results indicate that there is a 
clear difference in mechanism of bioactivity depending on whether the glass was amorphous or 
contained a fluoride-containing crystalline phase. 
Based on FTIR, XRD and 
31
P MAS-NMR data, the initially amorphous glasses containing relatively 
low amounts of fluoride (below 9% in Ca-containing and below 4.5% in Sr-containing series) 
degraded rapidly upon immersion in Tris buffer and formed apatite within 3 h. Results from  
19
F MAS-NMR revealed that the apatite, which formed within 6 h in Tris, was fluorapatite.  
No crystalline CaF2 phase was detected after immersion for glasses with low fluoride contents. 
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For dissolution studies in Tris buffer, the glass was the only source of phosphate for apatite 
formation. This proves that a high amount of phosphate present as orthophosphate in the bioactive 
glass is clearly beneficial for early apatite formation. The ionic concentration in solution confirm rapid 
glass degradation in Tris buffer. However, the results for phosphate were surprising, as concentrations 
observed for the initially amorphous glasses were very low, despite apatite having formed at very early 
immersion time points. This suggests that either phosphate was released at even earlier time points 
than the earliest investigated here (1 h), or apatite might form via a different mechanism than  
via dissolution-precipitation. 
The kinetics of glass degradation and apatite formation was slower in SBF compared to Tris buffer 
for the initially amorphous glasses, as seen particularly from comparison of FTIR spectra. Apatite 
formation was noted in SBF by 24 h compared to 6 h in Tris. This delay can be explained by the higher 
ionic strength of the SBF solution, which alters the kinetics of glass degradation via inhibiting the 
dissolution of ionic species. The presence of Mg
2+
 in SBF is known to suppress apatite formation [47] 
and can additionally contribute to a delayed formation of apatite [48]. 
Fluorapatite was not the only crystalline phase found in the partially crystallised glasses. Strong 
presence of CaF2 dominated in compositions with the highest fluoride contents starting from composition 
GF 13.6 with fluorapatite being present as a minor phase. However, the results presented above show 
that the fraction of crystalline apatite had grown in these bioceramics after immersion. The intensity of 
the signal assigned to apatite increased from XRD and FTIR. In addition, 
31
P MAS-NMR suggested an 
increase of the apatite fraction after immersion in Tris. 
The decrease in phosphate concentrations from 1 h in solution confirms a consumption of phosphate 
for apatite formation. The phosphate concentrations for the partially crystallised glasses was 
significantly higher than for the amorphous glasses, despite it being assumed that phosphate is released 
from the amorphous phase of the glass-ceramics rather than the crystalline. Despite this distinct 
difference, growth of the apatite fraction of the glass-ceramics is estimated to have occurred by 3–6 h, 
which is a similar time frame as for the amorphous glasses with low amounts of fluoride. 
Presence of apatite crystals in the untreated materials, even in minor amounts compared to the 
amorphous part, clearly affected the bioactivity of the glass-ceramics during immersion. The observed 
increase in the apatite fraction with time indicates that the existing apatite crystals served as a seeding 
phase for further apatite crystal growth. As the amorphous phase of the glass-ceramics rapidly 
degraded with time in buffer solution, the additional apatite had precipitated from the solution via a 
dissolution-precipitation mechanism. Presence of a seeding phase reduces the energy required for 
formation of apatite nuclei, which is typically the limiting factor of apatite crystallisation. Comparison 
of apatite formation for (partially crystalline) glass-ceramics immersed in Tris and SBF showed that 
there was no significant difference in the kinetics between the two solutions unlike for the amorphous 
glasses. This is owing to elimination of the rate limiting stage of apatite nucleation for the partially 
crystallised glass-ceramics. 
There was no significant difference between the Ca- and Sr-containing series, except for a higher 
tendency of the Sr-containing glasses to crystallise. 
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3. Experimental Section 
3.1. Glass Preparation 
A melt-quench method was employed to synthesise sodium-free, fluoride-containing bioactive 
glasses. The glasses were designed by introducing different amounts of CaF2/SrF2 into a  
SiO2-P2O5-CaO/SrO glass system (Table 1). In order to preserve the predominantly Q
2
 glass structure, 
calcium fluoride was added to the glasses with the ratios between other components kept constant. 
Table 1. Glass compositions in mol%. 
Glass code SiO2 CaO/SrO P2O5 CaF2/SrF2 
GF/SF 0.0 38.1 55.5 6.3 0.0 
GF/SF 3.0 37.0 53.9 6.1 3.0 
GF/SF 4.5 36.4 53.0 6.0 4.5 
GF/SF 6.0 35.9 52.2 5.9 6.0 
GF/SF 9.3 34.6 50.4 5.7 9.3 
GF/SF 13.6 32.9 48.0 5.5 13.6 
GF/SF 17.8 31.4 45.7 5.2 17.8 
GF/SF 25.5 28.4 41.4 4.7 25.5 
A 200 g batch of analytical grade silica (Prince Minerals Ltd., Stoke-on-Trent, UK), calcium 
carbonate, calcium fluoride and phosphorus pentoxide (Sigma-Aldrich, Gillingham, UK) were 
weighed out, mixed and transferred into a 300 mL platinum/rhodium crucible, melted at 1550 °C 
(glasses with 0 and 3 mol% CaF2/SrF2) and 1500 °C (all other glasses) for 1 h in an electrical furnace 
(EHF 17/3, Lenton, Hope Valley, UK). The melted glasses were quenched into cold deionised water to 
suppress crystallisation. The as-quenched granular glass frits were dried overnight and ground into 
powder by using a Gyro mill (Glen Creston, London, UK) for two sets of 7 min. A mesh analytical 
sieve (Endecotts Ltd., London, UK) with a size of 45 µm was applied to obtain fine powder. 
3.2. Bioactivity Testing and Ion Release Measurements 
Glass and glass-ceramics bioactivity was tested in Tris buffer solution and SBF. SBF was prepared 
following the recipe described by Kokubo and Takadama [2] for the corrected SBF (c-SBF).  
The preparation of Tris buffer solution was according to that described by Mneimne et al. [10].  
The specimens were prepared in duplicate; 75 mg of glass powder was dispersed in 50 mL of buffer 
solution and transferred to a shaking incubator (KS 4000i Control, IKA, Staufen, Germany) at  
37  1 °C at an agitation rate of 60 rpm for 1, 3, 6, 9, 24, 72 and 168 h. 
pH was measured using an Oakton
®
 pH meter with 35811-71 pH electrode at the end of each 
immersion period. The solutions were filtered using the filter papers with pore size of 5–13 μm and 
precipitates were collected. The filtered solution was kept at 4 °C until further analysis. 
The filtered solutions were acidified with 69% nitric acid to quantify ions concentrations using an 
inductively coupled plasma-optical emission spectroscopy (ICP-OES; Varian Vista-PRO, Yarnton, 
UK). The solutions were diluted by a factor 1:20 for measurements of the calcium and silicon content 
and no dilution was used for measurements of phosphate ion content. Calibrations were performed 
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using diluted multi-element stock solution. Fluoride content in solution was quantified using a fluoride 
ion selective electrode (Orion 9609BN, 710A meter, South Burlington, VT, USA) and NaF stock 
solution was used for preparation of the fluoride-containing calibration solutions. 
3.3. Characterisation of Apatite Formation after Immersion 
The precipitates collected after the immersion were dried and analyzed by X-ray Diffraction (XRD), 
Fourier Transform Infrared Spectroscopy (FTIR) and solid state Nuclear Magnetic Resonance (NMR). 
An X’Pert Pro X-ray diffractometer (PANalytical, Eindhoven, The Netherlands) with a copper  
(Ni-filtered Cu-Kα) X-ray source was employed to characterise the glasses, glass-ceramics and the 
samples collected after immersion in buffer solutions. The patterns of powder samples were recorded 
between 5 and 70° 2θ at a step size of 0.0334°. Calibration was carried out using NIST standard 
reference material 660a (lanthanum hexaboride). XRD data were analyzed using X’Pert HighScore 
Plus (v2.0, PANalytical, Almelo, The Netherlands) in conjunction with the ICDD database. 
The samples collected after immersion were assessed using Fourier Transform Infrared 
Spectroscopy (Spectrum GX, Perkin-Elmer, Cambridge, UK). The data were recorded from 500 to 
1600 cm
−1
 of wavenumber. 
Powders of the CaF2-containing glasses after soaking in buffer solutions were investigated using 
solid state NMR on a 600 MHz (14.1T) Bruker NMR spectrometer (Bruker AV 600 NMR, Conventry, 
UK). 
31
P MAS-NMR was run at the 242.9 MHz resonance frequency using a standard single resonance 
Bruker probe in a 4 mm rotor at spinning conditions of 8 and 10 kHz. Sixteen scans were run with a 
recycle delay of 60 s for each sample. The chemical shift was referenced using the primary reference, 
85% H3PO4. 
19
F MAS-NMR measurements were run at the 564.7 MHz resonance frequency using a 
standard double resonance Bruker probe with low fluorine background for a 2.5 mm rotor spinning at a 
speed of 18 kHz and 21 kHz. Typically, 32 or 64 scans were acquired with eight preliminary dummy 
scans and 30 s recycling delay. The chemical shift was referenced using the signal from 1M NaF 
solution scaled to −120 ppm relative to the CF3Cl primary standard. The free dmfit software [44] was 
used for deconvolution of the NMR spectra. 
4. Conclusions  
Amorphous glasses with low amounts of fluoride (below 9 mol% CaF2) degraded rapidly in Tris 
buffer solution and formed apatite within 3 h, which by 6 h could be identified as fluorapatite by  
19
F MAS-NMR. Glass degradation and apatite formation were significantly slower in SBF compared 
to Tris buffer. 
Partially crystallised glasses (containing crystalline phases such as fluorapatite or calcium/strontium 
fluoride) showed degradation of the amorphous phase and an increase in fraction of apatite by 3–6 h in 
Tris and SBF buffers, with no difference in kinetics observed for the two solutions. The increase in 
apatite fraction is thought to occur by precipitation of apatite onto the surface of apatite crystals 
already present within the glass-ceramics. High phosphate concentrations at 1 h followed by a decrease 
were observed for the glass-ceramics, which is in contrast to the amorphous glasses. It is proposed that 
two different mechanisms of apatite formation occur, depending on presence or absence of apatite 
crystals in the original glass. 
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